| Literature DB >> 23266021 |
Aimi Kawano1, Yoshihiro Tanaka, Yoshinobu Ishitobi, Yoshihiro Maruyama, Tomoko Ando, Ayako Inoue, Shizuko Okamoto, Junko Imanaga, Masayuki Kanehisa, Haruka Higuma, Taiga Ninomiya, Jusen Tsuru, Jotaro Akiyoshi.
Abstract
Salivary α-amylase (sAA) serves as a marker of sympathoadrenal medullary system (SAM) activity. Salivary AA has not been extensively studied in obsessive-compulsive disorder (OCD) patients. In the current study, 45 OCD patients and 75 healthy volunteers were assessed with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), the Profile of Mood State (POMS), and the State-Trait Anxiety Inventory (STAI). Measures of heart rate variability (HRV), sAA, and salivary cortisol were also obtained following the application of electrical stimulation stress. The Y-BOCS and POMS Tension-Anxiety, Depression-Dejection, Anger-Hostility, Fatigue, and Confusion scores were significantly increased in patients with OCD compared with healthy controls. In contrast, Vigor scores were significantly decreased in patients with OCD relative to scores in healthy controls. There was no difference in HRV between the patients and the controls. Salivary AA levels in female and male OCD patients were significantly elevated relative to controls both before and after electrical stimulation. In contrast, there were no differences in salivary cortisol levels between OCD patients and controls. The elevated secretion of sAA before and after stimulation may suggest an increased responsiveness to novel and uncontrollable situations in patients with OCD. An increase in sAA might be a characteristic change of OCD.Entities:
Keywords: 2-Chloro-4-nitrophenyl-4-O-β-d-galactopyranosylmaltoside; ACTH; ANOVA; ANS; Adrenocorticotropic hormone; Analysis of variance; Autonomic nervous system; CgA; Chromogranin A; Combined dexamethasone suppression/corticotropin releasing hormone stimulation test; DSM-IV; Dex/CRH; Diagnostic and Statistical Manual of Mental Disorders Fourth Edition; ELISA; Enzyme-linked immunosorbent assay; Gal-G2-CNP; HAM-D; HF; HPA; HRV; Hamilton Rating Scale for Depression; Heart rate variability; High-frequency; Hypothalamic–pituitary–adrenal; Hypothalamic–pituitary–adrenal axis; LC; LF; Locus coeruleus; Low-frequency; MDD; MINI; Major depressive disorder; Mini-International Neuropsychiatric Interview; OCD; Obsessive–compulsive disorder; POMS; Profile of Mood Statec; S.D.; SAM; SNP; SNRI; SNS; SSRI; STAI; Salivary cortisol; Salivary α-amylase; Selective norepinephrine reuptake inhibitors; Selective serotonin reuptake inhibitors; Single nucleotide polymorphism; Standard deviation; State-Trait Anxiety Inventory, Y–BOCS, Yale–Brown Obsessive–Compulsive Scale; Sympathetic nervous system; Sympathoadrenal medullary; Sympathoadrenal medullary activity; sAA
Mesh:
Substances:
Year: 2012 PMID: 23266021 DOI: 10.1016/j.psychres.2012.11.010
Source DB: PubMed Journal: Psychiatry Res ISSN: 0165-1781 Impact factor: 3.222